Clinical Trials Directory

Trials / Conditions / Stage IIIA Lung Non-Small Cell Cancer AJCC v7

Stage IIIA Lung Non-Small Cell Cancer AJCC v7

19 registered clinical trials studyying Stage IIIA Lung Non-Small Cell Cancer AJCC v7 — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingLocal Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chem
NCT04892953
M.D. Anderson Cancer CenterPhase 2
CompletedNivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-II
NCT03158129
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingTesting the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) M
NCT02503722
National Cancer Institute (NCI)Phase 1
Active Not RecruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
NCT02498613
National Cancer Institute (NCI)Phase 2
CompletedOsimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic N
NCT02520778
National Cancer Institute (NCI)Phase 1
Active Not RecruitingNivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (A
NCT02595944
National Cancer Institute (NCI)Phase 3
CompletedFLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PE
NCT02773238
University of WashingtonPhase 2
TerminatedGenetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
NCT02706392
Fred Hutchinson Cancer CenterPhase 1
CompletedMethoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With St
NCT02535325
National Cancer Institute (NCI)Phase 1
TerminatedNintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small
NCT02452463
Roswell Park Cancer InstitutePhase 2
Active Not RecruitingErlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Compl
NCT02193282
National Cancer Institute (NCI)Phase 3
Active Not RecruitingGenetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be R
NCT02194738
National Cancer Institute (NCI)N/A
TerminatedTrametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell
NCT01912625
National Cancer Institute (NCI)Phase 1
UnknownStudy of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With St
NCT01507428
National Cancer Institute (NCI)Phase 2
Active Not RecruitingVeliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small
NCT01386385
National Cancer Institute (NCI)Phase 1 / Phase 2
TerminatedCarboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung C
NCT01413750
National Cancer Institute (NCI)Phase 2
CompletedChemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small
NCT00324805
National Cancer Institute (NCI)Phase 3
Active Not RecruitingCombination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage I
NCT00334815
National Cancer Institute (NCI)Phase 2
CompletedDocetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Ca
NCT00254384
M.D. Anderson Cancer CenterPhase 1